Arcutis raises ~$161.6M in public offering of 18.2M shares at $9.50

Arcutis Biotherapeutics, Inc.

Issued ~18.2M shares at $9.50 via underwritten public offering, raising ~$161.6M net.
Underwriters fully exercised 30-day option to purchase additional 2,368,421 shares on Feb 29, 2024.
Net proceeds intended to fund commercialization, development, and approval for atopic dermatitis, scalp psoriasis, and psoriasis expansion.
Offering conducted under existing Form S-3 shelf registration (File No. 333-276794).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.